HARVARD BIOSCIENCE, INC. Interest Income (Expense), Nonoperating, Net
HARVARD BIOSCIENCE, INC. (HBIO) reported Interest Income (Expense), Nonoperating, Net of -$1.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$1.79M.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was -$1.73M.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was -$2.36M.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was -$966.00K.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2025 was -$4.92M.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2024 was -$3.54M.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2023 was -$3.59M.
- HARVARD BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2022 was -$2.55M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 6 month as first filed | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.79M 10-Q · filed 2026-08-11 | -$3.52M 10-Q · filed 2026-08-11 | -$5.88M derived: sum of 3 quarters · filed 2026-08-11 | -$6.84M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$1.73M 10-Q · filed 2026-05-12 | -$4.09M derived: sum of 2 quarters · filed 2026-05-12 | -$5.05M derived: sum of 3 quarters · filed 2026-05-12 | -$6.05M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$3.32M derived: sum of 2 quarters · filed 2026-03-13 | -$4.33M derived: sum of 3 quarters · filed 2026-08-11 | -$4.92M 10-K · filed 2026-03-13 | |||
| 2025-09-30 | -$966.00K 10-Q · filed 2025-11-06 | -$1.97M derived: sum of 2 quarters · filed 2026-08-11 | -$2.56M 10-Q · filed 2025-11-06 | -$4.08M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | -$1.00M 10-Q · filed 2026-08-11 | -$791.00K 10-Q · filed 2025-08-11 | -$1.93M 10-Q · filed 2026-08-11 | -$1.59M 10-Q · filed 2025-08-11 | -$3.11M derived: sum of 3 quarters · filed 2026-08-11 | -$3.97M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | -$933.00K 10-Q · filed 2026-05-12 | -$802.00K 10-Q · filed 2025-05-12 | -$2.11M derived: sum of 2 quarters · filed 2026-05-12 | -$2.97M derived: sum of 3 quarters · filed 2026-05-12 | -$3.72M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.04M derived: sum of 2 quarters · filed 2026-03-13 | -$2.79M derived: sum of 3 quarters · filed 2026-03-13 | -$3.54M 10-K · filed 2026-03-13 | -$3.21M 10-K · filed 2025-03-14 | ||
| 2024-09-30 | -$856.00K 10-Q · filed 2025-11-06 | -$1.60M derived: sum of 2 quarters · filed 2025-11-06 | -$2.36M 10-Q · filed 2025-11-06 | -$3.15M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$749.00K 10-Q · filed 2025-08-11 | -$1.50M 10-Q · filed 2025-08-11 | -$2.29M derived: sum of 3 quarters · filed 2025-08-11 | -$3.18M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | -$751.00K 10-Q · filed 2025-05-12 | -$1.54M derived: sum of 2 quarters · filed 2025-05-12 | -$2.43M derived: sum of 3 quarters · filed 2025-05-12 | -$3.37M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$794.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$1.68M derived: sum of 2 quarters · filed 2025-03-14 | -$2.62M derived: sum of 3 quarters · filed 2025-03-14 | -$3.59M 10-K · filed 2025-03-14 | |||
| 2023-09-30 | -$882.00K 10-Q · filed 2024-11-08 | -$1.82M derived: sum of 2 quarters · filed 2024-11-08 | -$2.80M 10-Q · filed 2024-11-08 | -$3.70M derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | -$941.00K 10-Q · filed 2024-08-08 | -$1.92M 10-Q · filed 2024-08-08 | -$2.81M derived: sum of 3 quarters · filed 2024-08-08 | -$3.56M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$974.00K 10-Q · filed 2024-05-07 | -$1.87M derived: sum of 2 quarters · filed 2024-05-07 | -$2.62M derived: sum of 3 quarters · filed 2024-05-07 | -$3.14M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$1.65M derived: sum of 2 quarters · filed 2024-03-07 | -$2.16M derived: sum of 3 quarters · filed 2024-03-07 | -$2.55M 10-K · filed 2024-03-07 | |||
| 2022-09-30 | -$749.00K 10-Q · filed 2023-11-07 | -$1.26M derived: sum of 2 quarters · filed 2023-11-07 | -$1.65M 10-Q · filed 2023-11-07 | -$2.03M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | -$515.00K 10-Q · filed 2023-08-08 | -$899.00K 10-Q · filed 2023-08-08 | -$1.28M derived: sum of 3 quarters · filed 2023-08-08 | -$1.65M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | -$384.00K 10-Q · filed 2023-04-26 | -$763.00K derived: sum of 2 quarters · filed 2023-04-26 | -$1.14M derived: sum of 3 quarters · filed 2023-04-26 | -$1.51M derived: sum of 4 quarters · filed 2023-04-26 | |||
| 2021-12-31 | -$379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$752.00K derived: sum of 2 quarters · filed 2023-03-09 | -$1.13M derived: sum of 3 quarters · filed 2023-03-09 | -$1.54M 10-K · filed 2023-03-09 | |||
| 2021-09-30 | -$373.00K 10-Q · filed 2022-11-09 | -$750.00K derived: sum of 2 quarters · filed 2022-11-09 | -$1.16M 10-Q · filed 2022-11-09 | -$2.25M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | -$377.00K 10-Q · filed 2022-08-04 | -$788.00K 10-Q · filed 2022-08-04 | -$1.88M derived: sum of 3 quarters · filed 2022-08-04 | -$3.09M derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | -$411.00K 10-Q · filed 2022-05-04 | -$1.50M derived: sum of 2 quarters · filed 2022-05-04 | -$2.71M derived: sum of 3 quarters · filed 2022-05-04 | -$3.94M derived: sum of 4 quarters · filed 2022-05-04 | |||
| 2020-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$2.30M derived: sum of 2 quarters · filed 2022-03-11 | -$3.53M derived: sum of 3 quarters · filed 2022-03-11 | -$4.83M 10-K · filed 2022-03-11 | |||
| 2020-09-30 | -$1.21M 10-Q · filed 2021-11-05 | -$2.44M derived: sum of 2 quarters · filed 2021-11-05 | -$3.74M 10-Q · filed 2021-11-05 | -$5.02M derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2020-06-30 | -$1.23M 10-Q · filed 2021-08-06 | -$2.53M 10-Q · filed 2021-08-06 | -$3.81M derived: sum of 3 quarters · filed 2021-08-06 | -$5.16M derived: sum of 4 quarters · filed 2021-08-06 | |||
| 2020-03-31 | -$1.30M 10-Q · filed 2021-05-07 | -$2.58M derived: sum of 2 quarters · filed 2021-05-07 | -$3.93M derived: sum of 3 quarters · filed 2021-05-07 | -$5.30M derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | -$1.28M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | -$2.63M derived: sum of 2 quarters · filed 2021-03-17 | -$4.00M derived: sum of 3 quarters · filed 2021-03-17 | -$5.41M 10-K/A · filed 2021-03-17 | |||
| 2019-09-30 | -$1.35M 10-Q · filed 2020-11-06 | -$2.72M derived: sum of 2 quarters · filed 2020-11-06 | -$4.13M 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | -$1.38M 10-Q · filed 2020-08-10 | -$2.78M 10-Q · filed 2020-08-10 | |||||
| 2019-03-31 | -$1.41M 10-Q · filed 2020-05-08 | ||||||
| 2018-12-31 | -$5.37M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |